SLC8A1 (Sodium/calcium exchanger 1) variants and mutations
SLC8A1 (also known as Sodium/calcium exchanger 1) is a human protein-coding gene encoding a sodium/calcium exchanger 1 protein. It exchanges intracellular calcium for extracellular sodium and is a major route for calcium extrusion in cardiomyocytes after contraction. Altered activity can strongly influence calcium loading and arrhythmogenesis, while rare pathogenic variants cause cardiac and neurodevelopmental phenotypes. This analysis covers 1,757 SLC8A1 variants and mutations. Of these, 59% have computational variant effect predictions. Disease context includes Abnormality of the skeletal system, hypertensive disorder, and smoking initiation. Example SLC8A1 variants include Y2*, Y2F, and N3D.
Variant analysis overview
- Gene: SLC8A1
- Protein: Sodium/calcium exchanger 1
- UniProt accession: P32418
- Organism: Homo sapiens
- Variants analyzed: 1757
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 1,451 unspecified-consequence records; 1 stop retained variant; 1 stop lost; 110 synonymous variants; 181 missense variants; 4 frameshift variants; 2 in-frame deletions; 1 in-frame insertions; 3 stop-gained variants; 2 splice-region variants; 1 substitution
- Prediction scores: 1,039 variants have prediction scores (59% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Abnormality of the skeletal system, hypertensive disorder, smoking initiation, essential hypertension, bone fracture, ulna fracture, radius fracture, Bicuspid aortic valve, Abnormality of refraction, type 1 diabetes nephropathy, brain aneurysm, Epstein-Barr virus infection.
Protein structure and variant hotspots
- Protein features: 10 transmembrane segments; 2 domains; 27 binding sites; 4 post-translational modification sites.
- Structural context: 652 variants have structural context.
- PTM context: 6 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SLC8A1 variants
Examples include Y2*, Y2F, N3D, N3H, N3S, M4I, M4T, R5L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- Y2* (p.Tyr2Ter), ExAC rs768751346, TOPMed rs768751346, gnomAD rs768751346, CADD 34.00
- Y2F (p.Tyr2Phe), rs115564742, ClinGen CA1627826, ClinVar RCV000923916, 1000Genomes rs115564742, REVEL 0.04, CADD 1.89, Likely benign, not provided
- N3D (p.Asn3Asp), rs747307904, ClinGen CA1627824, ClinVar RCV004293091, ExAC rs747307904, REVEL 0.04, CADD 13.40, Uncertain significance, not specified
- N3H (p.Asn3His), ExAC rs747307904, TOPMed rs747307904, gnomAD rs747307904, REVEL 0.05, CADD 14.80, Uncertain significance
- N3S (p.Asn3Ser), ExAC rs780255113, TOPMed rs780255113, gnomAD rs780255113, REVEL 0.04, CADD 7.65
- M4I (p.Met4Ile), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, NCI-TCGA Cosmic COSV6049, cosmic curated COSV60494, Variant assessed as somatic; moderate impact.
- M4T (p.Met4Thr), NCI-TCGA Cosmic COSV6048, cosmic curated COSV60487, Variant assessed as somatic; moderate impact.
- R5L (p.Arg5Leu), ESP rs139897746, ExAC rs139897746, TOPMed rs139897746, gnomAD rs139897746, REVEL 0.11, CADD 7.66
- R5P (p.Arg5Pro), ESP rs139897746, ExAC rs139897746, TOPMed rs139897746, gnomAD rs139897746, REVEL 0.28, CADD 8.94
- R5Q (p.Arg5Gln), cosmic curated COSV60469, ESP rs139897746, ExAC rs139897746, TOPMed rs139897746, REVEL 0.02, CADD 7.06
- R5W (p.Arg5Trp), cosmic curated COSV60476, ESP rs200360506, ExAC rs200360506, TOPMed rs200360506, REVEL 0.08, CADD 19.60
- R6* (p.Arg6Ter), cosmic curated COSV10441, ExAC rs767111343, TOPMed rs767111343, gnomAD rs767111343, CADD 35.00
- R6Q (p.Arg6Gln), cosmic curated COSV60482, ESP rs202097070, ExAC rs202097070, TOPMed rs202097070, REVEL 0.02, CADD 1.12
- S8N (p.Ser8Asn), cosmic curated COSV60494, 1000Genomes rs199547343, ExAC rs199547343, TOPMed rs199547343, REVEL 0.02, CADD 2.36, Uncertain significance
- S8T (p.Ser8Thr), rs199547343, ClinGen CA1627813, ClinVar RCV004222573, 1000Genomes rs199547343, REVEL 0.06, CADD 1.60, Uncertain significance, not specified
- L9I (p.Leu9Ile), rs773071951, NCI-TCGA Cosmic COSV6047, cosmic curated COSV60474, ExAC rs773071951, REVEL 0.08, CADD 14.00, Variant assessed as somatic; moderate impact.
- L9P (p.Leu9Pro), Ensembl rs1697957885
- L9V (p.Leu9Val), ExAC rs773071951, TOPMed rs773071951, gnomAD rs773071951, REVEL 0.08, CADD 13.20
- S10L (p.Ser10Leu), cosmic curated COSV10647, TOPMed rs879070799
- S10P (p.Ser10Pro), Ensembl rs2149788408
- P11A (p.Pro11Ala), gnomAD rs1311147797, REVEL 0.06, CADD 13.20
- P11H (p.Pro11His), ExAC rs761802445, gnomAD rs761802445, REVEL 0.17, CADD 24.30
- P11L (p.Pro11Leu), ExAC rs761802445, gnomAD rs761802445, REVEL 0.12, CADD 22.10
- P11S (p.Pro11Ser), cosmic curated COSV10519, REVEL 0.05, CADD 14.60
- T12I (p.Thr12Ile), ESP rs142661656, ExAC rs142661656, TOPMed rs142661656, gnomAD rs142661656, REVEL 0.03, CADD 7.05, Uncertain significance, not specified
- T12S (p.Thr12Ser), rs142661656, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, ESP rs142661656, REVEL 0.02, CADD 5.02, Variant assessed as somatic; moderate impact.
- F13L (p.Phe13Leu), gnomAD rs1421364412, REVEL 0.05, CADD 15.30
- S14L (p.Ser14Leu), cosmic curated COSV10024, REVEL 0.10, CADD 18.40
- S14P (p.Ser14Pro), TOPMed rs1365148622, gnomAD rs1365148622, REVEL 0.09, CADD 18.20
- M15I (p.Met15Ile), TOPMed rs1253383021, gnomAD rs1253383021, REVEL 0.04, CADD 14.80, Uncertain significance, not specified
- M15K (p.Met15Lys), ExAC rs772267395, gnomAD rs772267395, REVEL 0.09, CADD 17.10
- M15V (p.Met15Val), ExAC rs780349585, TOPMed rs780349585, gnomAD rs780349585, REVEL 0.03, CADD 2.07, Uncertain significance, not specified
- G16R (p.Gly16Arg), cosmic curated COSV10519
- G16V (p.Gly16Val), cosmic curated COSV60470, gnomAD rs1258924118, REVEL 0.16, CADD 17.00
- H18N (p.His18Asn), cosmic curated COSV60500
- H18Y (p.His18Tyr), NCI-TCGA Cosmic COSV6049, cosmic curated COSV60493, NCI-TCGA Cosmic COSV6050, Variant assessed as somatic; moderate impact.
- L19V (p.Leu19Val), ExAC rs746239822, gnomAD rs746239822, REVEL 0.04, CADD 15.50
- L20F (p.Leu20Phe), TOPMed rs989112001, gnomAD rs989112001, REVEL 0.04, CADD 11.20
- V21A (p.Val21Ala), NCI-TCGA Cosmic COSV1002, Variant assessed as somatic; moderate impact.
- V21D (p.Val21Asp), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, Variant assessed as somatic; moderate impact.
- V21F (p.Val21Phe), TOPMed rs1697940400, gnomAD rs1697940400
- V21I (p.Val21Ile), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, Variant assessed as somatic; moderate impact.
- V21L (p.Val21Leu), TOPMed rs1697940400, gnomAD rs1697940400, REVEL 0.03, CADD 7.50
- T22A (p.Thr22Ala), Ensembl rs1697939794, REVEL 0.02, CADD 0.35
- T22I (p.Thr22Ile), 1000Genomes rs143231281, ESP rs143231281, ExAC rs143231281, TOPMed rs143231281, REVEL 0.07, CADD 4.54
- T22S (p.Thr22Ser), 1000Genomes rs143231281, ESP rs143231281, ExAC rs143231281, TOPMed rs143231281, REVEL 0.05, CADD 3.67
- S24R (p.Ser24Arg), TOPMed rs751105395, gnomAD rs751105395, REVEL 0.06, CADD 4.67
- S24T (p.Ser24Thr), Ensembl rs2149788190, REVEL 0.04, CADD 6.63
- L25F (p.Leu25Phe), cosmic curated COSV60495
- F27L (p.Phe27Leu), NCI-TCGA TCGA novel, gnomAD rs1316390677, REVEL 0.04, CADD 5.10, Variant assessed as somatic; moderate impact.
- S28F (p.Ser28Phe), NCI-TCGA Cosmic COSV6049, cosmic curated COSV60493, Variant assessed as somatic; moderate impact.
- S28Y (p.Ser28Tyr), TOPMed rs1226702240, REVEL 0.08, CADD 6.79
- H29Y (p.His29Tyr), TOPMed rs1033058020
- V30L (p.Val30Leu), ESP rs138232364, TOPMed rs138232364, gnomAD rs138232364, REVEL 0.05, CADD 3.30
- D31Y (p.Asp31Tyr), cosmic curated COSV60495
- H32N (p.His32Asn), gnomAD rs1697930570, REVEL 0.03, CADD 6.83
- H32P (p.His32Pro), cosmic curated COSV10647
- H32R (p.His32Arg), TOPMed rs1234364602, gnomAD rs1234364602, REVEL 0.07, CADD 0.06
- V33I (p.Val33Ile), cosmic curated COSV60498
- V33L (p.Val33Leu), cosmic curated COSV60499
- I34T (p.Ile34Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A35C (p.Ala35Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- A35G (p.Ala35Gly), gnomAD rs1280344450, REVEL 0.18, CADD 22.90
- A35T (p.Ala35Thr), gnomAD rs1353379967, REVEL 0.14, CADD 22.70
- E36D (p.Glu36Asp), ExAC rs780535144, TOPMed rs780535144, gnomAD rs780535144, REVEL 0.03, CADD 9.23
- E36K (p.Glu36Lys), Ensembl rs2149788032, Uncertain significance, not specified
- E36V (p.Glu36Val), cosmic curated COSV10590, TOPMed rs1697926541
- T37A (p.Thr37Ala), ExAC rs113726948, gnomAD rs113726948, REVEL 0.04, CADD 8.74
- T37I (p.Thr37Ile), gnomAD rs1300165896, REVEL 0.07, CADD 16.00
- T37R (p.Thr37Arg), gnomAD rs1300165896, REVEL 0.11, CADD 14.10
- E38G (p.Glu38Gly), gnomAD rs1440308785, REVEL 0.10, CADD 21.40
- E38K (p.Glu38Lys), TOPMed rs1697923336
- M39I (p.Met39Ile), Ensembl rs1057186496
- M39R (p.Met39Arg), TOPMed rs1697922016, REVEL 0.04, CADD 15.30
- E40K (p.Glu40Lys), cosmic curated COSV10813
- G41E (p.Gly41Glu), cosmic curated COSV60478, Ensembl rs1697920651
- E42* (p.Glu42Ter), cosmic curated COSV60480
- E42K (p.Glu42Lys), NCI-TCGA Cosmic COSV6048, Variant assessed as somatic; moderate impact.
- G43A (p.Gly43Ala), ExAC rs751120817, gnomAD rs751120817, REVEL 0.01, CADD 11.20
- G43E (p.Gly43Glu), NCI-TCGA Cosmic COSV6047, cosmic curated COSV60477, ExAC rs751120817, gnomAD rs751120817, REVEL 0.02, CADD 14.60, Variant assessed as somatic; moderate impact.
- G43V (p.Gly43Val), NCI-TCGA Cosmic COSV6047, Variant assessed as somatic; moderate impact.
- E45G (p.Glu45Gly), Ensembl rs934644722
- E45K (p.Glu45Lys), rs763896494, cosmic curated COSV10519, TOPMed rs763896494, gnomAD rs763896494, REVEL 0.05, CADD 12.80, Variant assessed as somatic; moderate impact.
- T46A (p.Thr46Ala), NCI-TCGA Cosmic COSV6047, cosmic curated COSV60472, REVEL 0.07, CADD 18.90, Variant assessed as somatic; moderate impact.
- T46N (p.Thr46Asn), cosmic curated COSV60499, REVEL 0.13, CADD 18.90
- G47C (p.Gly47Cys), cosmic curated COSV60488
- G47R (p.Gly47Arg), ExAC rs766064333, gnomAD rs766064333, REVEL 0.08, CADD 14.70
- G47V (p.Gly47Val), TOPMed rs1697916340
- E48* (p.Glu48Ter), NCI-TCGA Cosmic COSV6048, cosmic curated COSV60481, Variant assessed as somatic; high impact.
- E48K (p.Glu48Lys), cosmic curated COSV60483
- C49S (p.Cys49Ser), TOPMed rs1188111178, gnomAD rs1188111178, REVEL 0.50, CADD 25.50
- T50I (p.Thr50Ile), ExAC rs762666688, TOPMed rs762666688, gnomAD rs762666688, REVEL 0.10, CADD 23.50, Uncertain significance, not specified
- T50S (p.Thr50Ser), ExAC rs762666688, TOPMed rs762666688, gnomAD rs762666688, REVEL 0.17, CADD 21.60
- Y53H (p.Tyr53His), cosmic curated COSV60491, Ensembl rs547557363
- C55G (p.Cys55Gly), NCI-TCGA Cosmic COSV6049, Variant assessed as somatic; moderate impact.
- C55R (p.Cys55Arg), cosmic curated COSV60491
- K56N (p.Lys56Asn), NCI-TCGA Cosmic COSV6047, cosmic curated COSV60471, Variant assessed as somatic; moderate impact.
- K56R (p.Lys56Arg), cosmic curated COSV10813, NCI-TCGA Cosmic COSV6047, Variant assessed as somatic; moderate impact.
- K56T (p.Lys56Thr), NCI-TCGA Cosmic COSV6047, cosmic curated COSV60479, Variant assessed as somatic; moderate impact.
- K57R (p.Lys57Arg), 1000Genomes rs200355004, ExAC rs200355004, gnomAD rs200355004, REVEL 0.03, CADD 17.30
- G58A (p.Gly58Ala), Ensembl rs1697910790
- G58R (p.Gly58Arg), NCI-TCGA TCGA novel, REVEL 0.61, CADD 25.70, Variant assessed as somatic; moderate impact.
- G58V (p.Gly58Val), cosmic curated COSV10590
- V59L (p.Val59Leu), NCI-TCGA TCGA novel, REVEL 0.16, CADD 17.80, Variant assessed as somatic; moderate impact.
- I60M (p.Ile60Met), ExAC rs761710337, gnomAD rs761710337, REVEL 0.22, CADD 18.30
- I60V (p.Ile60Val), gnomAD rs1244261232
- L61S (p.Leu61Ser), NCI-TCGA Cosmic COSV6047, cosmic curated COSV60479, Variant assessed as somatic; moderate impact.
- P62A (p.Pro62Ala), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, Variant assessed as somatic; moderate impact.
- P62H (p.Pro62His), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, Variant assessed as somatic; moderate impact.
- P62L (p.Pro62Leu), gnomAD rs1338732026, REVEL 0.58, CADD 27.10
- P62S (p.Pro62Ser), TOPMed rs1338928156, gnomAD rs1338928156, REVEL 0.49, CADD 25.80
- I63F (p.Ile63Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- I63S (p.Ile63Ser), gnomAD rs1697904401, REVEL 0.41, CADD 24.10
- I63V (p.Ile63Val), NCI-TCGA TCGA novel, REVEL 0.05, CADD 15.70, Variant assessed as somatic; moderate impact.
- W64* (p.Trp64Ter), cosmic curated COSV10519, cosmic curated COSV60477
- E65* (p.Glu65Ter), NCI-TCGA Cosmic COSV6048, Variant assessed as somatic; high impact.
- E65G (p.Glu65Gly), TOPMed rs756315238, gnomAD rs756315238, REVEL 0.16, CADD 22.70
- E65K (p.Glu65Lys), cosmic curated COSV60485, Ensembl rs1697902992, REVEL 0.11, CADD 17.60
- P66R (p.Pro66Arg), Ensembl rs2149787674
- P66T (p.Pro66Thr), TOPMed rs1690502060, REVEL 0.72, CADD 25.50
- Q67* (p.Gln67Ter), cosmic curated COSV10441
- Q67H (p.Gln67His), cosmic curated COSV60480, NCI-TCGA Cosmic COSV6048, REVEL 0.11, CADD 16.50, Variant assessed as somatic; moderate impact.
- Q67K (p.Gln67Lys), gnomAD rs1697900280, REVEL 0.09, CADD 17.60
- D68N (p.Asp68Asn), gnomAD rs1237906514, REVEL 0.07, CADD 17.80
- D68Y (p.Asp68Tyr), NCI-TCGA Cosmic COSV6047, cosmic curated COSV60474, Variant assessed as somatic; moderate impact.
- P69L (p.Pro69Leu), Ensembl rs1576429924, REVEL 0.36, CADD 22.60
- P69S (p.Pro69Ser), ExAC rs764034216, TOPMed rs764034216, gnomAD rs764034216, REVEL 0.36, CADD 22.30
- S70F (p.Ser70Phe), cosmic curated COSV60480, REVEL 0.55, CADD 27.30
- F71S (p.Phe71Ser), ExAC rs760822866, gnomAD rs760822866, REVEL 0.33, CADD 23.10
- G72A (p.Gly72Ala), ExAC rs772335407, TOPMed rs772335407, gnomAD rs772335407, REVEL 0.30, CADD 20.80
- G72W (p.Gly72Trp), Ensembl rs1697895687
- D73N (p.Asp73Asn), ESP rs372921563, ExAC rs372921563, gnomAD rs372921563, REVEL 0.42, CADD 25.90
- K74R (p.Lys74Arg), cosmic curated COSV10441, TOPMed rs1317534057, gnomAD rs1317534057, REVEL 0.19, CADD 21.00
- K74T (p.Lys74Thr), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, NCI-TCGA Cosmic COSV1044, TOPMed rs1317534057, Variant assessed as somatic; moderate impact.
- I75N (p.Ile75Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A76D (p.Ala76Asp), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, Variant assessed as somatic; moderate impact.
- A76G (p.Ala76Gly), cosmic curated COSV10610
- A76S (p.Ala76Ser), gnomAD rs1238192528, REVEL 0.21, CADD 24.70
- R77I (p.Arg77Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R77S (p.Arg77Ser), ExAC rs771460733, gnomAD rs771460733
- A78T (p.Ala78Thr), Ensembl rs1697890840, REVEL 0.28, CADD 25.60
- T79I (p.Thr79Ile), TOPMed rs897284573, REVEL 0.17, CADD 18.40
- T79N (p.Thr79Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T79S (p.Thr79Ser), TOPMed rs897284573
- V80L (p.Val80Leu), cosmic curated COSV99064, NCI-TCGA Cosmic COSV9906, Variant assessed as somatic; moderate impact.
- V80M (p.Val80Met), gnomAD rs1441415024, REVEL 0.36, CADD 25.40
- Y81C (p.Tyr81Cys), rs1245804817, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, Ensembl rs1245804817, Variant assessed as somatic; moderate impact.
- A84S (p.Ala84Ser), cosmic curated COSV60490
- A84V (p.Ala84Val), ExAC rs778365438, gnomAD rs778365438
- V86F (p.Val86Phe), Ensembl rs1389858088
- V86I (p.Val86Ile), NCI-TCGA TCGA novel, REVEL 0.09, CADD 15.40, Variant assessed as somatic; moderate impact.
- Y87* (p.Tyr87Ter), NCI-TCGA Cosmic COSV6048, cosmic curated COSV60483, Variant assessed as somatic; high impact.
- M88L (p.Met88Leu), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, NCI-TCGA Cosmic COSV6049, cosmic curated COSV60491, Variant assessed as somatic; moderate impact.
- M88V (p.Met88Val), gnomAD rs1345230389, REVEL 0.29, CADD 23.00
- F89L (p.Phe89Leu), Ensembl rs538636773
- L90I (p.Leu90Ile), Ensembl rs752927856, REVEL 0.21, CADD 23.60
- L90P (p.Leu90Pro), cosmic curated COSV60479
- L90R (p.Leu90Arg), NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, NCI-TCGA Cosmic COSV6047, Variant assessed as somatic; moderate impact.
- G91E (p.Gly91Glu), Ensembl rs2149787414
- G91R (p.Gly91Arg), cosmic curated COSV10813, Ensembl rs2149787425
- G91V (p.Gly91Val), cosmic curated COSV10741
- S93C (p.Ser93Cys), NCI-TCGA Cosmic COSV6048, NCI-TCGA Cosmic COSV6049, cosmic curated COSV60493, REVEL 0.74, CADD 27.10, Variant assessed as somatic; moderate impact.
- S93F (p.Ser93Phe), NCI-TCGA Cosmic COSV6048, cosmic curated COSV60487, NCI-TCGA Cosmic COSV6049, Variant assessed as somatic; moderate impact.
- I94L (p.Ile94Leu), Ensembl rs1559653969
- I94V (p.Ile94Val), Ensembl rs1559653969, REVEL 0.33, CADD 24.90
- I95T (p.Ile95Thr), cosmic curated COSV60474, Ensembl rs2149787372
- I95V (p.Ile95Val), rs140571640, ClinGen CA1627780, ClinVar RCV004296274, 1000Genomes rs140571640, REVEL 0.17, CADD 23.00, Uncertain significance, not specified
- A96T (p.Ala96Thr), NCI-TCGA TCGA novel, TOPMed rs1697879086, gnomAD rs1697879086, REVEL 0.81, CADD 25.70, Uncertain significance, not specified
- D97N (p.Asp97Asn), NCI-TCGA TCGA novel, TOPMed rs1697878423, REVEL 0.76, CADD 26.20, Variant assessed as somatic; moderate impact.
- R98Q (p.Arg98Gln), cosmic curated COSV10024, gnomAD rs1379346196, REVEL 0.67, CADD 26.60
- R98W (p.Arg98Trp), rs1559653918, NCI-TCGA Cosmic COSV6047, cosmic curated COSV60477, Ensembl rs1559653918, REVEL 0.62, CADD 26.10, Variant assessed as somatic; moderate impact.
- F99L (p.Phe99Leu), cosmic curated COSV10519
- M100I (p.Met100Ile), rs1235809764, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, TOPMed rs1235809764, Variant assessed as somatic; moderate impact.
- M100L (p.Met100Leu), ExAC rs779494411, TOPMed rs779494411, gnomAD rs779494411, REVEL 0.50, CADD 25.90
- S101Y (p.Ser101Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S102F (p.Ser102Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T107I (p.Thr107Ile), NCI-TCGA Cosmic COSV6047, cosmic curated COSV60475, REVEL 0.78, CADD 25.90, Variant assessed as somatic; moderate impact.
- Q109* (p.Gln109Ter), NCI-TCGA Cosmic COSV6047, NCI-TCGA Cosmic COSV6049, cosmic curated COSV60497, Variant assessed as somatic; high impact.
- Q109E (p.Gln109Glu), cosmic curated COSV60494
- Q109K (p.Gln109Lys), cosmic curated COSV60475, Ensembl rs78410508
Public SLC8A1 analysis runs
- SLC8A1 analysis run — SLC8A1 (1,757 variants) — completed 2026-08-20